ArticleBlood advances2020

Mn porphyrins as a novel treatment targeting sickle cell NOXs to reverse and prevent acute vaso-occlusion in vivo.

Madhan Thamilarasan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.